Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

184
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
184
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

680
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
680
Drug Delivery: Overview01:16

Drug Delivery: Overview

719
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chitosan Nanoparticles in Pulmonary Drug Delivery: Unleashing the Potential for Targeted and Effective Therapy.

Chemistry & biodiversity·2026
Same author

Editorial: Neuromuscular disorders: biomarkers, precision diagnosis, and targeted therapeutics.

Frontiers in neuroscience·2026
Same author

Nanostructured implants for enhanced integration and localized therapy.

BioImpacts : BI·2026
Same author

3D-Printing-Assisted Fabrication and Characterization of Pregabalin-Loaded PVA/PVP Dissolving Microneedle Arrays.

Micromachines·2026
Same author

Bioactive Anti-Inflammatory Compounds and Therapeutic Strategies for Promoting Resolution.

Pharmaceutics·2026
Same author

Postnatal Care Utilisation Among Adolescent Mothers in India: A Pooled Cross-Sectional Study of NFHS-4 and NFHS-5.

Public health challenges·2026

Related Experiment Video

Updated: Jan 14, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

11.1K

Liposomal Drug Delivery for Neurological Disorders: Advances and Challenges.

Aysha Javed1, Purba Mandal1, Imran Khan1

  • 1Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 226026, India.

Central Nervous System Agents in Medicinal Chemistry
|October 24, 2025
PubMed
Summary

Liposomal drug delivery offers a promising approach for treating neurological illnesses by enhancing medication transport to the brain. Despite challenges like stability and scalability, advanced liposome formulations show potential for improved therapeutic outcomes.

Keywords:
Alzheimer's diseaseLiposomal drug deliveryParkinson's diseasebioavailabilityblood-brain barrier (BBB)multiple sclerosis.stroke

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

5.8K

Related Experiment Videos

Last Updated: Jan 14, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

11.1K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

5.8K

Area of Science:

  • Neuroscience
  • Biotechnology
  • Pharmacology

Background:

  • Liposomal drug delivery systems are emerging as effective strategies for neurological disease treatment.
  • These systems protect medications from degradation and improve bioavailability for brain delivery.
  • Formulation strategies like surface modification enhance liposome-drug interactions and brain targeting.

Purpose of the Study:

  • To explore the potential of liposomal drug delivery for treating various neurological conditions.
  • To discuss the mechanisms by which liposomes cross the blood-brain barrier (BBB).
  • To identify challenges and future directions for clinical translation.

Main Methods:

  • Utilizing liposomes for targeted delivery of therapeutic agents across the blood-brain barrier.
  • Employing formulation strategies such as surface modification and remote loading.
  • Investigating liposome interactions with the BBB via passive diffusion and receptor-mediated transcytosis.

Main Results:

  • Liposomal formulations demonstrate potential for targeted drug delivery in Parkinson's, Alzheimer's, stroke, multiple sclerosis, and brain cancers.
  • Liposomes can enhance the efficacy of neuroprotective agents and chemotherapy drugs.
  • Surface modification and techniques like PEGylation improve liposome stability, targeting, and reduce immunogenicity.

Conclusions:

  • Liposomal drug delivery holds significant promise for transforming neurological disease treatment.
  • Overcoming challenges in scalability, stability, and immunogenicity requires multidisciplinary collaboration.
  • Further research and technological advancements are crucial for realizing the full therapeutic potential of liposomes in brain diseases.